Transcription Factor Program 2 (TFP2)

Transcription Factor Program 2 (TFP2) is not a specific biological molecule or receptor but rather a designation for a drug discovery program, most notably associated with Kronos Bio's pipeline. In the context of biotech development, such programs typically focus on identifying and targeting transcription factors or their regulatory networks that are dysregulated in diseases like cancer. While Kronos Bio has disclosed specific targets for other programs, such as CDK9 for KB-0742 and p300 for KB-9558, the specific molecular target for TFP2 remains proprietary or undisclosed in general scientific literature. Consequently, it does not represent a canonical therapeutic target with defined biological functions or established drug interactions. Analysts should treat this term as a corporate project identifier rather than a distinct molecular entity.

Other names

TFP-2Transcription Factor Program 2 (Kronos Bio)

Unknown